AdisInsight to Support Business and Investment Decisions

We connect all the data. You get all the insights.

Are you a Finance/Investment Analyst or Consulting company looking for a reliable and comprehensive source of information on drugs and their development? Look no further than AdisInsight!

AdisInsight brings together the most essential information you need to identify and advise on business and investment opportunities in the Pharma & Biotech markets, in one comprehensive, easy-to-use database. With up-to-date and reliable information on drugs in development, including clinical trial data, regulatory status and patent information, Finance/Investment Analysts can make better strategic decisions about which drugs and companies to invest in.  

The earning potential of a specific drug still in R&D can greatly affect the stock valuation of the company responsible for research. Consulting companies can use AdisInsight to stay up-to-date with the latest developments in the industry, write their own reports, and provide informed recommendations to their clients. Besides access to breaking news in the industry, AdisInsight provides detailed information on the regulatory status of drugs in development, helping consulting companies to better assess the current and future competitive landscape by therapy area.

Get AdisInsight today and take your investment and consulting strategies to the next level!

Get in touch

Fill out the form below to talk to one of our experts and/or to request a demo - a representative will get in touch with you shortly.

Your GPS to Pharma and Biotech Investing

Download the resources below to find out more:

Why AdisInsight?

AdisInsight can help Finance/Investment Analysts and Consulting companies stay informed about drugs in development, identify investment opportunities and support consulting engagements. With AdisInsight Timelines API, drug development information can be used as an alternative data source to determine trading strategies based on back testing historical drug development information against changes in the market. 

Get a global perspective of the most compelling current evidence driving drug development to: